BridgeMD
New treatment option for Chronic Knee Pain
Official title Sequential Genicular Nerve Ablation Prior to Geniculate Artery Embolization in Knee Pain
ClinicalTrials.gov ID: NCT06514755
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate whether performing genicular nerve ablation (GNA) before geniculate artery embolization (GAE) improves pain relief and knee function in patients with chronic knee pain. The main questions it aims to answer are: Does performing GNA prior to GAE enhance pain relief, as measured by the Visual Analog Scale (VAS), at 3 months post-procedure?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adults aged 18 to 80 years.
- Diagnosed with chronic knee pain refractory to conservative treatment.
- Able to provide informed consent.
- Agree to follow the study procedures and attend follow-up visits.
You likely can't join if
- Contraindications to GNA or GAE procedures (e.g., allergy to local anesthetics, active infection at the procedure site).
- Recent knee surgery within the last six months.
- Severe comorbid conditions that may interfere with the study outcomes (e.g., rheumatoid arthritis, other severe autoimmune diseases).
- Current participation in another clinical trial that could interfere with the outcomes of this study.
The study team makes the final eligibility decision.
Where it's taking place
- Zagazig, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zagazig, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.